TY - JOUR
T1 - Cellular and Molecular Mechanisms of Prion Disease
AU - Sigurdson, Christina J.
AU - Bartz, Jason C.
AU - Glatzel, Markus
N1 - Funding Information:
M.G. is funded by the Federal Ministry of Education and Research, the German Research Foundation, and the Herz Foundation (UndoAD, SFB877, Infectophysics). C.J.S. is supported in part by grants from the US National Institutes of Health (NS069566, NS0756896, and NS105498).
Publisher Copyright:
© 2019 by Annual Reviews. All rights reserved.
PY - 2019
Y1 - 2019
N2 - Prion diseases are rapidly progressive, incurable neurodegenerative disorders caused by misfolded, aggregated proteins known as prions, which are uniquely infectious. Remarkably, these infectious proteins have been responsible for widespread disease epidemics, including kuru in humans, bovine spongiform encephalopathy in cattle, and chronic wasting disease in cervids, the latter of which has spread across North America and recently appeared in Norway and Finland. The hallmark histopathological features include widespread spongiform encephalopathy, neuronal loss, gliosis, and deposits of variably sized aggregated prion protein, ranging from small, soluble oligomers to long, thin, unbranched fibrils, depending on the disease. Here, we explore recent advances in prion disease research, from the function of the cellular prion protein to the dysfunction triggering neurotoxicity, as well as mechanisms underlying prion spread between cells. We also highlight key findings that have revealed new therapeutic targets and consider unanswered questions for future research.
AB - Prion diseases are rapidly progressive, incurable neurodegenerative disorders caused by misfolded, aggregated proteins known as prions, which are uniquely infectious. Remarkably, these infectious proteins have been responsible for widespread disease epidemics, including kuru in humans, bovine spongiform encephalopathy in cattle, and chronic wasting disease in cervids, the latter of which has spread across North America and recently appeared in Norway and Finland. The hallmark histopathological features include widespread spongiform encephalopathy, neuronal loss, gliosis, and deposits of variably sized aggregated prion protein, ranging from small, soluble oligomers to long, thin, unbranched fibrils, depending on the disease. Here, we explore recent advances in prion disease research, from the function of the cellular prion protein to the dysfunction triggering neurotoxicity, as well as mechanisms underlying prion spread between cells. We also highlight key findings that have revealed new therapeutic targets and consider unanswered questions for future research.
UR - http://www.scopus.com/inward/record.url?scp=85060526221&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85060526221&partnerID=8YFLogxK
U2 - 10.1146/annurev-pathmechdis-012418-013109
DO - 10.1146/annurev-pathmechdis-012418-013109
M3 - Review article
C2 - 30355150
AN - SCOPUS:85060526221
SN - 1553-4006
VL - 14
SP - 497
EP - 516
JO - Annual Review of Pathology: Mechanisms of Disease
JF - Annual Review of Pathology: Mechanisms of Disease
ER -